SUSAN BLANEY to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
This is a "connection" page, showing publications SUSAN BLANEY has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Connection Strength
0.040
-
Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortium. J Clin Oncol. 2011 Mar 01; 29(7):839-44.
Score: 0.022
-
Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults. Cancer Chemother Pharmacol. 2009 Jan; 63(2):229-38.
Score: 0.018